All In Biotech

Drug Trial Radar · NCT07860203

Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery

Effects of Stellate Ganglion Block Combined With Dexmedetomidine on Postoperative Sleep Quality in Patients Undergoing Laparoscopic Gynecological Surgery: A Randomized Controlled 2×2 Factorial Trial

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Oct 2026

Primary completion

Dec 2026

Study completion Jan 2027

Sponsor

Lead sponsor
Catherin ZhangAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study Objectives This study aims to investigate the effects of preoperative stellate ganglion block and intraoperative intravenous dexmedetomidine on postoperative sleep disturbance in patients undergoing laparoscopic gynecologic surgery, with the goals of reducing pain and postoperative adverse reactions and identifying an effective, safe, economical, and broadly applicable intervention strategy that may facilitate emergence from anesthesia, accelerate postoperative recovery, shorten the length of hospital stay, and reduce hospitalization costs. This trial aims to determine whether preoperative stellate ganglion block (SGB) and intraoperative intravenous dexmedetomidine (DEX) can improve postoperative sleep quality in patients undergoing laparoscopic gynecologic surgery, and whether the combination of these two interventions provides an interaction effect or additional ben

Conditions

  • Uterine Fibroids (Leiomyoma)
  • Adenomyosis of Uterus
  • Endometriosis
  • Endometrial Cancer
  • Cervical Cancer
  • Ovarian Cancer

Interventions

  • DEX 0.2 μg/kg/h.Drug

    Dexmedetomidine is administered by intravenous infusion after induction of anesthesia without a loading dose, at an infusion rate of 0.2μg·kg-¹·h-¹, and continued until the end of surgery.

  • SGBProcedure

    Stellate ganglion block (SGB) is performed 15 min after induction of anesthesia by an anesthesiologist experienced in ultrasound-guided regional anesthesia, who is aware of the patient's group assignment. The patient is placed in the supine position with the neck slightly extended and rotated to the contralateral side. Under sterile conditions, a high-frequency linear-array ultrasound transducer is used to scan the anterior neck transversely at the C6 level, sequentially identifying the common carotid artery, internal jugular vein, thyroid gland, esophagus, C6 transverse process and anterior tubercle, longus colli muscle, and surrounding vascular structures. In the SGB group, an in-plane needle approach is used under real-time ultrasound guidance. After the needle tip reaches the fascial plane anterior to the longus colli muscle and negative aspiration for blood is confirmed, 5 mL of 0.375% ropivacaine is injected slowly. Spread of the local anesthetic along the surface of the longus

  • 0.9% Sodium Chloride (Placebo)Drug

    An equal volume of 0.9% sodium chloride solution is administered by intravenous infusion after induction of anesthesia as a placebo for dexmedetomidine and continued until the end of surgery.

  • Sham Stellate Ganglion BlockProcedure

    Participants are placed in the same position as those receiving the stellate ganglion block, and the ultrasound probe is placed on the neck in an identical manner to simulate the procedure. No needle puncture or drug injection is performed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. St. Mary's Hospital Sleep Questionnaire Score 1 Day Before SurgeryTime frame: 1 day before surgery(ΡRE)
  2. Total Sleep Time 1 Day Before SurgeryTime frame: 1 day before surgery(PRE)
  3. Wake After Sleep Onset 1 Day Before SurgeryTime frame: 1 day before surgery(PRE)
  4. Sleep Efficiency 1 Day Before SurgeryTime frame: 1 day before surgery(PRE)
  5. St. Mary's Hospital Sleep Questionnaire Score on Postoperative Day 1Time frame: Postoperative Day 1(POD1)
  6. Total Sleep Time on Postoperative Day 1Time frame: Postoperative day 1
  7. Wake After Sleep Onset on Postoperative Day 1Time frame: Postoperative day 1(ΡOD1)
  8. Sleep Efficiency on Postoperative Day 1Time frame: Postoperative day 1(ΡOD1)
  9. St. Mary's Hospital Sleep Questionnaire Score on Postoperative Day 2Time frame: Postoperative Day 2(ΡOD2)
  10. Total Sleep Time on Postoperative Day 2Time frame: Postoperative day 2
  11. Wake After Sleep Onset on Postoperative Day 2Time frame: Postoperative day 2(POD2)
  12. Sleep Efficiency on Postoperative Day 2Time frame: Postoperative day 2(POD2)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Huai'an Second People's Hospital

    Huai'an, Jiangsu, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.